Raltegravir-induced nephrolithiasis: A case report

AIDS

Volumn 26, Issue 10, 2012, Pages 1323-1324

  Vassallo, Matteo ^a   Dunais, Brigitte ^a   Naqvi, Alissa ^a   Garaffo, Rodolphe ^b   Durant, Jacques ^a  

^a Infectious Diseases Department   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DARUNAVIR; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RALTEGRAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; DRUG URINE LEVEL; ESCHERICHIA COLI INFECTION; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FEVER; FLANK PAIN; HEMATURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LEUKOCYTURIA; LITHOTOMY; NEPHROLITHIASIS; PRIORITY JOURNAL; PYELONEPHRITIS; URINARY TRACT INFECTION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; NEPHROLITHIASIS; PYRROLIDINONES; RECURRENCE;

EID: 84862736238     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328353fda1     Document Type: Letter

References (8)

1. Jao J, Wyatt CM. Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis 2010; 17:72-82.
2. Cicconi P, Bongiovanni M, Melzi S, Tordato F, d'Arminio Monforte A, Bini T. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir. Int J Antimicrob Agents 2004; 24:284-285.
3. Huynh J, Hever A, Tom T, Sim JJ. Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy. Int Urol Nephrol 2011; 43:571-573.
4. Feicke A, Rentsch KM, Oertle D, Strebel RT. Same patient, new stone composition: amprenavir urinary stone. Antivir Ther 2008; 13:733-734.
5. Izzedine H, M'rad MB, Bardier A, Daudon M, Salmon D. Atazanavir crystal nephropathy. AIDS 2007; 21:2357-2358.
6. Chan-Tack KM, Truffa MM, Struble KA, Birnkrant DB. Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS 2007; 21:1215-1218. (Pubitemid 46763296)
7. Nadler RB, Rubenstein JN, Eggener SE, Loor MM, Smith ND. The etiology of urolithiasis in HIV infected patients. J Urol 2003; 169:475-477. (Pubitemid 36132965)
8. Kassahun K, McIntosh I, Cui D, Hreniuk D, Merschman S, Lasseter K, et al. Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme. Drug Metab Dispos 2007; 35:1657-1663; Epub 2007 Jun 25. (Pubitemid 47296061)